For citations:
Semiglazov V.F., Bekkeldieva N.B., Krivorotko P.V., Komyakhov A.V., Paltuev R.M., Tseluyko A.I., Gigolaeva L.P., Tabagua T.T., Zhiltsova E.K., Apollonova V.S., Dashyan G.A., Kudaybergenova A.G., Ivanov V.G., Bozhok A.A., Ulrikh D.G., Gorina A.O., Semiglazova T.Yu. Improving treatment outcomes for patients with HER2‑positive breast cancer using neoadjuvant double HER2 blockade. Tumors of female reproductive system. 2024;20(3):16-21. (In Russ.) https://doi.org/10.17650/1994-4098-2024-20-3-16-21
Email this article 